Updates in the Treatment of HR+ Breast Cancer : Episode 6
Opinion
Video
Updates in Treatment Approaches With CDK4/6 Inhibitors in HR+ Breast Cancer
A panel of experts discuss treatment updates in regards to CDK4/6 inhibitors.
Video content above is prompted by the following:
- What are the CDK4/6i options?
- Please briefly review the main clinical trials and recent data.
- How do the data for the 3 CDK4/6i compare?
Related Videos
Related Content
